Elevated plasma fibrinogen levels as an independent prognostic marker in breast cancer patients

被引：0
|
作者：
Krenn-Pilko, S. [1 ]
Langsenlehner, U. [2 ]
Thurner, E. -M [1 ]
Stojakovic, T. [3 ]
Pichler, M. [4 ]
Gerger, A. [5 ]
Kapp, K. S. [1 ]
Langsenlehner, T. [1 ]
机构：
[1] Med Univ Graz, Univ Klin Strahlentherapie & Radioonkol, Graz, Austria
[2] Steiermark Gebietskankenkasse, Graz, Austria
[3] Med Univ Graz, Klin Inst Med & Chem Labordiagnost, Graz, Austria
[4] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX USA
[5] Med Univ Graz, Klin Abt Onkol, Graz, Austria
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2014年 / 190卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [41] CD4 levels as a prognostic marker for metastatic breast cancer
    Boyle, H. J.
    Tredan, O.
    Chabaud, S.
    Bajard, A.
    Perol, D.
    Bachelot, T. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [42] Elevated expression of LIMK2 is an independent prognostic indicator in breast cancer
    Sun, Peng
    Ren, Lin
    Chen, Qing-Qiu
    Tan, Xuan-Ni
    Zhang, Ting
    Li, Yan-Ling
    Zhang, Fan
    Jiang, Jun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (06): : 5929 - 5936
  • [43] Evaluating the potential of circulating hTERT levels in glioma: can plasma levels serve as an independent prognostic marker?
    Puneet Gandhi
    Richa Khare
    Nitin Garg
    Journal of Neuro-Oncology, 2017, 135 : 255 - 261
  • [44] Evaluating the potential of circulating hTERT levels in glioma: can plasma levels serve as an independent prognostic marker?
    Gandhi, Puneet
    Khare, Richa
    Garg, Nitin
    JOURNAL OF NEURO-ONCOLOGY, 2017, 135 (02) : 255 - 261
  • [45] Overexpression of LAPTM4B: an independent prognostic marker in breast cancer
    Xiao, Min
    Jia, Shusheng
    Wang, Hongbin
    Wang, Jinsong
    Huang, Yuanxi
    Li, Zhigao
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (04) : 661 - 667
  • [46] Quantitative assessment of miR34a as an independent prognostic marker in breast cancer
    Agarwal, Seema
    Hanna, J.
    Sherman, M. E.
    Figueroa, J.
    Rimm, D. L.
    BRITISH JOURNAL OF CANCER, 2015, 112 (01) : 61 - 68
  • [47] CD133 is an independent predictive and prognostic marker in metastatic breast cancer
    Hefni, Ahmed Mubarak
    Sayed, Ayat Mohammed
    Hussien, Marwa T.
    Abdalla, Ashraf Zeidan
    Gabr, Adel Gomaa
    CANCER BIOMARKERS, 2022, 35 (02) : 207 - 215
  • [48] 17β-hydroxysteroid dehydrogenase type 1 is an independent prognostic marker in breast cancer
    Oduwole, OO
    Li, Y
    Isomaa, VV
    Mäntyniemi, A
    Pulkka, AE
    Soini, Y
    Vihko, PT
    CANCER RESEARCH, 2004, 64 (20) : 7604 - 7609
  • [49] Prolactin Receptor Expression is an Independent Favorable Prognostic Marker in Human Breast Cancer
    Hachim, Ibrahim Y.
    Hachim, Mahmood Y.
    Lopez, Vanessa M.
    Lebrun, Jean-Jacques
    Ali, Suhad
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2016, 24 (04) : 238 - 245
  • [50] Pretreatment plasma fibrinogen level as a prognostic biomarker for patients with lung cancer
    Zhang, Yi
    Cao, Junyan
    Deng, Yinan
    Huang, Yiming
    Li, Rong
    Lin, Guozhen
    Dong, Min
    Huang, Zenan
    CLINICS, 2020, 75
12345